NEW YORK (GenomeWeb) – Agilent Technologies reported after the close of the market on Monday that its fourth quarter revenues grew 9 percent year over year.

For the three months ended Oct. 31, the life sciences company said total revenues rose to $1.29 billion from $1.19 billion in Q4 2017, beating the analysts' average estimate of $1.25 billion. Core revenues also rose 9 percent.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The Washington Post reports on a Federal Bureau of Investigation plan to place rapid DNA analyzers at booking stations around the country.

In an editorial, officials from scientific societies in the US and China call for the international community to develop criteria and standards for human germline editing.

The US National Institutes of Health is to review studies that have received private support for conflicts of interest, according to the New York Times.

In Science this week: the PsychENCODE Consortium reports on the molecular mechanisms of neuropsychiatric disorders, and more.